Adtec visits Taiwan for SteriPlas expansion project

 

Who better to facilitate the expansion of the SteriPlas Premium Cold Plasma in the SE Asia market but the leading medical distributor, SG Biomedical. Adtec Healthcare Limited joins SG Biomedical in Taiwan to complete the introduction of three SteriPlas medical devices in the leading wound care hospitals.

Over 30 patients have so far been treated ranging from Diabetic Foot Ulcers, LVAD infections, Burn wounds, Vascular and Orthopaedic wounds and so on. All patients have had chronic infection with biofilm prior to being introduced to the SteriPlas. Some wounds have been non-healing for 4 years!

 

We are happy to report that over continued twice weekly use over the last two months, all patients are responding very well with most having been fully healed and no relapse of infection.

 

If you are within the Taiwan region and you are interested to learn more, please contact us so that we may introduce you to our partner.


Update to clinical section on our website

 

We have recently updated the clinical section of our website to illustrate the proven antibacterial efficacy of the Adtec SteriPlas: http://adtecplasma.com/clinical.html

 

Chronic and complex wounds that are often stalled by biofilm such as diabetic foot ulcers may find difficulty to heal using conventional treatment therapies. This also applies to deep surgical site infections in cardiac patients where the morbidity rate is usually high. Using our medical device to treat these complex conditions has shown to offer promising hope leading to full healing, even if biofilm has persisted to deteriorate the wound before. Patients have been saved from amputations and given a better Quality of Life.

 

Other than diabetic foot ulcers and surgical site infections, we have collected strong clinical efficacy for the treatment of dermatology skin conditions. We encourage you to contact us at info@adtec.eu.com to learn about the myriad of benefits that our leading cold plasma medical device can offer your patients.


Two new publications for our cold plasma treating surgical site infections

Congratulations to Dr Heinrich Rotering for two publications released this year documenting the treating of surgical site infections and infected drivelines with the Adtec SteriPlas.

 

His first publication this year, “Cold atmospheric plasma and advanced negative pressure wound therapy” features the unique combination of our Adtec SteriPlas medical device with NPWT. A link to the purchase of this paper can be found in the The Journal for Cardiac, Thoracic and Vascular Surgery on Springer Link: https://link.springer.com/article/10.1007/s00398-019-00355-0?fbclid=IwAR0O5Vh6i8QWtTuR7s8ha-10xwoJtd5n_YNY_NM5rQkDT8a8B9p9WWEKxBc

 

His second publication this year, “Preliminary Results of a New Treatment Strategy for Relapsed Left Ventricular Assist Device-Specific Infections” discusses how relapsed ventricular assist device-specific infections are associated with high morbidity, mortality, and hospital costs. A new combination of cold atmospheric plasma and special dressing technique with negative pressure wound therapy with an additional underlay of carbon cloth and hypochlorite rinsing solutions has been developed and reported in his study.

https://pubmed.ncbi.nlm.nih.gov/32169499/?fbclid=IwAR3jA0jwGoaeaui8tUQVbsw-snidQ0SivtareKAOnRntAxh1_38J7z2s8LA

 

Dr Rotering has already demonstrated the proven antibacterial efficacy of the Adtec SteriPlas for the treatment of deep surgical site infections and infected drivelines in previous conference presentations, and these papers further demonstrate the accelerated healing potential with the unique combination of the two treatment therapies.

 

We encourage you to read these publications to learn the benefits of the Adtec SteriPlas for the treatment of complicated and stalled wounds and surgical site infections.


Medical conferences postponed for 2020 due to COVID restrictions

With the ongoing COVID-19 lockdown, many medical conferences that we would usually exhibit have been postponed. This year’s conferences include the Malvern Diabetic Foot conference which is now postponed to 2021, the EWMA conference which is now postponed to 18th-20th November and the DFSG conference which will now be a virtual conference.

For customers and friends that we had already planned to meet at the conferences and can now no longer attend, we are happy to meet with you in person once the lockdown restrictions have been lifted. Until then, we are still contactable via our normal communication routes and welcome any discussions.

We wish everyone in our network to be safe and well.


Adtec Healthcare confirms attendance for 3rd conference in 2020

 

Adtec Healthcare looks forward to exhibiting at the Diabetic Foot Study Group (DFSG) conference in Bratislava, Slovakia between 18-20 September 2020.

You can find us at booth 13 in the exhibition hall where our staff will be ready to welcome you. We will also have our flagship medical device, the Adtec SteriPlas, live on demonstration to show you how easy it is to treat diabetic foot ulcers.

 

 

#plasma #coldplasma #kaltesplasma #gasplasma #DFSG #DFSG2020 #diabeticfootulcer #wound #woundcare #woundhealing #wundkongress #wund #medicaldevice #DFSG #DFSG2020


EWMA

We had a great time exhibiting at the EWMA 2019 conference. We would like to congratulate Maurice Moelleken, Dr Heinrich Rotering and Dr Michael Pierides for their brilliant presentations during the conference. Their data showed the strong benefits of using the Adtec SteriPlas on chronic wounds and surgical site infections, offering an alternative to standard treatment therapies that bacteria may pose a resistance to.

The Adtec SteriPlas has proven antibacterial efficacy backed by a wide clinical bibliography and no side effects reported making it safe, painless and effective for the treatment of infected wounds stalled by bacteria.

For more information send us an email to info@adtec.eu.com

Top left (Dr Michael Pierides), top right (Maurice Moelleken), bottom (Dr Heinrich Rotering)

#EWMA #EWMA2019 #antimicrobialresistance #medicaldevice
#gasplasma #coldplasma #kaltesplasma


Adtec Healthcare confirmed to exhibit at two conferences this year

Adtec Healthcare is excited to announce that we will be exhibiting at two conferences so far this year.

We will be exhibiting at The 136th Congress of the German Society of Surgery (http://www.chirurgie2019.de/) in Munich, Germany between the 26th-29th March 2019. Dr Heinrich Rotering will also be presenting “Infected Implant – Complex wound treatment: Cold atmospheric plasma and advanced NPWT” at this conference at 13:10 (GMT) on 29th March 2019. His presentation will feature our medical device, the Adtec SteriPlas. We will be located at booth no. 150 where we welcome you to visit us.

We will also be exhibiting at the European Wound Management Association (EWMA) conference in Gothenburg, Sweden (http://ewma.org/ewma-conference/2019/) between the 5th-7th June 2019. You can find us at booth B10:22 where we will have our Adtec SteriPlas medical device ready to give a live demonstration on its effectiveness and simplicity of use.

To arrange a meeting at either of these conferences, please contact us at info@adtec.eu.com


New Corporate Management Team at Adtec.

Adtec Europe is happy to announce a new President at our parent company Adtec Plasma Technology Co., Ltd Japan (listed on TSE 6668) - Mr Hidenori Morishita. Mr Morishita has been working at Adtec Japan for over 15 years primarily in the role of business development. 

Read more


Adtec Healthcare congratulates the R&D Manager Takuya Urayama on receipt of the second place award for Most Innovative Product at JWC Awards 2017.

Takuya is design leader for the Adtec SteriPlas gas plasma device. He also leads the team for development of Adtec microwave gas plasma devices in other applications such as sanitisation of hard to clean areas in food factories and surface treatment.  

Read more